TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LNTH

Lantheus Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

100.60$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Lantheus Holdings Inc (LNTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 1,542 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LNTH
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
356 288 284 302 293 302 331 343 347 339 425 935 1,296 1,534 1,542
261 213 206 176 158 164 169 168 173 201 238 353 587 546 600
95 75 77 126 136 138 162 175 175 139 188 582 710 988 942
41 41 30 14 14 12 18 17 20 33 45 312 78 168 177
33 33 33 37 44 39 50 50 61 69 150 134 125 194 275
112 111 99 86 93 88 110 110 123 143 249 546 345 531 631
-17 -0.8 -19 39 43 57 52 64 52 -4.2 -61 36 365 457 311
38 42 43 42 39 27 18 17 14 9.5 7.8 7.2 20 20 20
-53 -43 -61 -2.4 -12 28 40 50 29 -11 -75 27 411 431 314
84 -0.6 1.0 1.2 3.0 1.5 -84 9.0 -3.0 2.0 -3.8 -1.3 84 119 80
-137 -42 -62 -3.6 -15 27 123 41 32 -13 -71 28 327 312 234
18 27 7.5 58 47 73 77 81 56 23 -25 82 491 515 404

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?